Chemical Stimulation Of Growth Or Activity By Addition Of Chemical Compound Which Is Not An Essential Growth Factor; Stimulation Of Growth By Removal Of A Chemical Compound Patents (Class 435/244)
-
Patent number: 8426189Abstract: Fermentation media containing an isoflavone-depleted soybean meal or isoflavone-depleted soybean meal product and at least one exogenous added ingredient that comprises a substrate for microbial growth are provided. Methods of making a fermentation medium comprising an isoflavone-depleted soybean meal or isoflavone-depleted soybean meal product and methods for obtaining a fermentation product are also provided. The present invention is further directed to fermentation broths obtained by the media and methods. The present invention is also directed to feed additives produced from fermentation broths obtained by the methods.Type: GrantFiled: April 27, 2010Date of Patent: April 23, 2013Assignee: Fermalogic, Inc.Inventor: J. Mark Weber
-
Patent number: 8338143Abstract: This invention provides methods whereby taxol, baccatin III, and other taxol-like compounds, or taxanes, can be produced in very high yield from all known Taxus species, e.g., brevifolia, canadensis, cuspidata, baccata, globosa, floridana, wallichiana, media and chinensis. Particular modifications of culture conditions (i.e., media composition and operating modes) have been discovered to enhance the yield of various taxanes from cell culture of all species of Taxus. Particularly preferred enhancement agents include silver ion or complex, jasmonic acid (especially the methyl ester), auxin-related growth regulators, and inhibitors of the phenylpropanoid pathway, such as 3,4-methylenedioxy-6-nitrocinnamic acid. These enhancement agents may be used alone or in combination with one another or other yield-enhancing conditions. While the yield of taxanes from plant cell culture of T.Type: GrantFiled: December 17, 2010Date of Patent: December 25, 2012Assignee: Phyton Holdings, LLCInventors: Venkataraman Bringi, Prakash Kadkade, Christopher Prince, Braden Roach
-
Publication number: 20120322107Abstract: The invention encompasses the use of one or more compounds selected from a list comprising i) reduced forms of vitamin K and/or ii) reduced forms of a vitamin K analog and/or iii) reduced forms of a vitamin K precursor for the expression of one or more functional vitamin K-dependent proteins in cell culture as well as processes for the fermentation of eucaryotic cells expressing one or more vitamin K-dependent proteins wherein one or more compounds selected from a list comprising i) reduced forms of vitamin K and/or ii) reduced forms of a vitamin K analog and/or iii) reduced forms of a vitamin K precursor are added to the cell culture medium before and/or during the fermentation process.Type: ApplicationFiled: July 9, 2010Publication date: December 20, 2012Applicant: CSL LIMITEDInventors: Julian Keane, Anthony Stowers, Peter Soupourmas, Fraser Goodwin
-
Patent number: 8323949Abstract: Compositions of peptides and surface-active agents are described, as are methods of making and using such compositions. The compositions are capable of affecting metabolic rates in biological systems, and to accelerate nutrient uptake without a concomitant increase in biofilm production.Type: GrantFiled: December 15, 2008Date of Patent: December 4, 2012Assignee: Advanced BioCatalytics CorporationInventor: Carl W. Podella
-
Patent number: 8323942Abstract: The present invention is directed to methods for inducing desired activity in enzymes or microorganisms capable of producing the enzymes. The invention is further directed to methods of stabilizing activity in microorganisms. In specific embodiments, the invention provides methods for inducing and stabilizing nitrile hydratase activity, amidase activity, and asparaginase I activity. The invention further provides compositions comprising enzymes or microorganisms having induced and/or stabilized activity.Type: GrantFiled: April 3, 2009Date of Patent: December 4, 2012Assignee: Georgia State University Research FoundationInventors: George E. Pierce, Gene K. Drago, Sangeeta Ganguly
-
Publication number: 20120276245Abstract: The present invention discloses improved fermentation conditions for S. thermophilus and/or L. bulgaricus, allowing efficient preparation of fermented products based on monoculture of these strains. Such fermented products may be fermented food products or may be starter cultures for use in the preparation of fermented food products. The invention also describes the use of certain compounds for stimulating growth of S. thermophilus and/or L. bulgaricus.Type: ApplicationFiled: October 7, 2010Publication date: November 1, 2012Applicant: STICHTING TOP INSTITUTE FOOD AND NUTRITIONInventors: Johannes Epeüs Theodoor Van Hylckama Vlieg, Jeroen Hugenholtz, Franciscus Adrianus Maria De Bok, Sander Sieuwerts
-
Patent number: 8268601Abstract: A process for cultivating photosynthetic microbes comprising Closed Systems for continuous cultivation and Open Systems for batch cultivation, in which (a) the Closed System Area occupies no more than 20% of the Total Land Area of the cultivation facility; (b) batch cultures in the Open Systems are initiated with an inoculum from the Closed Systems containing a cell biomass of no less than 5% of the carrying capacity of said Open System; (c) the doubling rate of said photosynthetic microbe is no less than once every 16 hours; and (d) the residence time of the batch culture in said Open System is no more than a period of 5 days.Type: GrantFiled: August 6, 2010Date of Patent: September 18, 2012Assignee: HR Biopetroleum, Inc.Inventors: Mark Edward Huntley, Donald G Redalje
-
Patent number: 8263642Abstract: In one aspect, the invention relates to compounds and methods useful for activating heme sensor systems; for decreasing virulence of bacteria, for example, Staphylococcus aureus; pharmaceutical compositions comprising the compounds; and methods of treating microbial-related disorders. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.Type: GrantFiled: June 25, 2009Date of Patent: September 11, 2012Assignee: Vanderbilt UniversityInventors: Eric Skaar, Devin Stauff, Olusegun O. Aranmolate
-
Patent number: 8221997Abstract: To provide a microorganism capable of producing a large amount of carotenoids, mainly astaxanthin, and to provide a method of producing carotenoids using the microorganism, a microorganism having improved carotenoid productivity is used, which is obtainable by breeding a carotenoid producing Paracoccus bacteria which is featured by producing 720 mg or more carotenoid per 1 L of culture medium. Also used is a method of producing carotenoids using the bacterium.Type: GrantFiled: September 26, 2006Date of Patent: July 17, 2012Assignee: Tosoh CorporationInventors: Toru Tanaka, Teruhiko Ide, Kei-ichi Murayama, Seigou Oe, Toru Imaizumi, Satoshi Hanzawa, Toshinobu Toyoshima
-
Patent number: 8211668Abstract: A method of preparing a recombinant polypeptide of interest includes fermenting a host cell being transformed with a recombinant expression system capable of bringing about secretion of a polypeptide of interest into the periplasm of said host cell. The polypeptide of interest is extracted from the periplasm by applying a continuous osmotic shock to the host cells contained in a fermentation medium. An apparatus for osmotically shocking cells includes a first reservoir containing cells in a first solution and a second reservoir containing a second solution, the first solution having a higher osmolarity than the second solution. A method for osmotically shocking cells using the first and second solutions is also disclosed. Also disclosed is a method of isolating a recombinant polypeptide of interest from a cell.Type: GrantFiled: January 11, 2008Date of Patent: July 3, 2012Assignee: Dow AgroSciences, LLC.Inventors: Anant Y. Patkar, Subrata Sen, Micheal L. Chappell
-
Publication number: 20120107914Abstract: A compound selected from the group consisting of 4-quinolone and derivatives thereof, homoserine lactone derivatives, and indole and derivatives thereof, and salts thereof have an action of a microbial activity improvement agent, and when it is used for a microbial activity improvement method and a biological waste treatment method, the compound or the salt thereof is useful to achieve the improvement in the treatment capacity that transcends the limit of improvement in the treatment capacity of conventional biological waste treatment facilities.Type: ApplicationFiled: June 20, 2010Publication date: May 3, 2012Applicant: SUMITOMO HEAVY INDUSTRIES, LTD.Inventors: Hideki Inaba, Youhei Hashimoto, Nobuhiko Nomura, Masanori Toyofuku
-
Patent number: 8158403Abstract: A dead cell of a lactic acid bacterium or a culture containing the dead cell of a lactic acid bacterium is added to the dairy products such as yogurt, cheese, milk beverage or the like in an amount of 0.001 wt % or more in dry weight of the dead cell, therefore, it is possible to enhance the growth of a lactic acid bacterium, to shorten the time required for fermentation, and to improve the viability of a lactic acid bacterium during storage over a long period, without affecting the flavor or production cost of the dairy product.Type: GrantFiled: June 26, 2007Date of Patent: April 17, 2012Assignee: Megmilk Snow Brand Co., Ltd.Inventors: Mari Miura, Yasuyuki Seto, Masayuki Watanabe, Toshimitsu Yoshioka
-
Publication number: 20120045795Abstract: The present invention provides a cell capable of high-yield production of polypeptides and a method for producing the same. The present invention relates to a method for producing a cell capable of high-yield production of a desired polypeptide, wherein a strongly bicarbonate transporter-expressing cell into which DNA encoding the desired polypeptide has been introduced is cultured in the presence of a high concentration of methotrexate and a cell capable of high-yield production of the desired polypeptide is selected from among surviving cells.Type: ApplicationFiled: April 21, 2010Publication date: February 23, 2012Inventors: Hisahiro Tabuchi, Tomoya Sugiyama
-
Publication number: 20110300593Abstract: The invention relates to improvements in the production of alcohols by microbial fermentation, particularly to production of alcohols by microbial fermentation of a substrate comprising CO. It more particularly relates to the provision of an inorganic organic sulfur source to a fermentation system such that one or more micro-organisms convert a substrate comprising CO to alcohols. In a particular embodiment, a microbial culture is provided with sodium polysulfide, wherein a substrate comprising CO is converted to products including ethanol and 2,3-butanediol.Type: ApplicationFiled: November 30, 2009Publication date: December 8, 2011Applicant: LanzaTech New Zealand LimitedInventors: Christophe Daniel Mihalcea, Jennifer Mon Yee Fung, Bakir Al-Sinawi, Phuong Loan Tran
-
Patent number: 8058039Abstract: A process for the use of low concentration levels of Erythromycin to eliminate or control the growth of unwanted or undesirable bacteria (contaminating bacteria) in the fermentation production of alcohols without inhibition of the growth or replication of the yeast.Type: GrantFiled: March 13, 2008Date of Patent: November 15, 2011Assignee: North American Bioproducts CorporationInventors: Kevin E. Dailey, Kevin L. Kauers
-
Patent number: 8034602Abstract: Disclosed herein are a microorganism producing L-arginine and a method of producing L-arginine using the same. The microorganism is a mutant strain of the genus Corynebacterium, Corynebacterium glutamicum CJR0500. The method for L-arginine production comprises activating the mutant strain C. glutamicum CJR0500 in a fermentation medium at 30° C. for 16 hours and then culturing the activated mutant strain for 72 hours with shaking.Type: GrantFiled: July 12, 2007Date of Patent: October 11, 2011Assignee: CJ Cheiljedang CorporationInventors: Young Hoon Park, Hye Won Kim, Ji-Hye Lee, Soo-Youn Hwang
-
Publication number: 20110245207Abstract: The invention relates to biology and medicine, in particular, can be used in medicine for preparation of a pharmaceutical composition for specific, self-regulating uncoupling of mitochondria. The invention may be useful in treatment of diseases and conditions associated with violation of cellular metabolism, in treatment of obesity including its pathological forms, as well as in treatment of diseases associated with increased formation of free radicals and reactive oxygen species. In addition, the invention may be used in biotechnology for stimulation of growth of yeast and microorganisms as well as for stimulation of development of tissues and organs of plant and animal origin.Type: ApplicationFiled: November 12, 2008Publication date: October 6, 2011Applicant: MITOTECH SAInventors: Maxim V. Skulachev, Vladimir P. Skulachev
-
Patent number: 8003355Abstract: A method of separating a polymer from a biomass containing the polymer, includes contacting the biomass with a solvent system, the solvent system including a solvent for the polymer and a precipitant for the polymer, to provide a residual biomass and a solution that includes the polymer, the solvent for the polymer and the precipitant for the polymer; and applying a centrifugal force to the solution and residual biomass to separate at least some of the solution from the residual biomass; where, the polymer is a polyhydroxyalkanoate; the precipitant comprises at least one alkane; the solvent for the polymer is selected from the group consisting of ketones, esters and alcohols and combinations thereof; and the biomass comprises a slurry of the biomass and water.Type: GrantFiled: April 15, 2010Date of Patent: August 23, 2011Assignee: Metabolix, Inc.Inventors: Johan van Walsem, Luhua Zhong, Simon S. Shih
-
Patent number: 8003091Abstract: The present invention provides a method for purifying bacterial minicells that involves subjecting a sample containing minicells to density gradient centrifugation in a biologically compatible medium. The method optionally includes a preliminary differential centrifugation step and one or more filtration steps. The invention also provides a method for purifying bacterial minicells in which a sample containing minicells is subjected to a condition that induces parent bacterial cells to adopt a filamentous form, followed by filtration of the sample to separate minicells from parent bacterial cells. The inventive methods optionally include one or more steps to remove endotoxin from purified minicell preparations, and/or treatment of purified minicell preparations with an antibiotic. Additionally, the invention provides purified minicell preparations, prepared according to the foregoing methods, and containing fewer than about 1 contaminating parent bacterial cell per 107, 108, 109, 1010, or 1011 minicells.Type: GrantFiled: March 27, 2007Date of Patent: August 23, 2011Assignee: Engeneic Molecular Delivery Pty. Ltd.Inventors: Himanshu Brahmbhatt, Jennifer MacDiarmid
-
Publication number: 20110201091Abstract: A process for producing a microbial growth stimulant (MGS) from a plant biomass is described. An ammonium hydroxide solution is used to extract a solution of proteins and ammonia from the biomass. Some of the proteins and ammonia are separated from the extracted solution to provide the MGS solution. The removed ammonia can be recycled and the proteins are useful as animal feeds.Type: ApplicationFiled: August 29, 2007Publication date: August 18, 2011Applicant: Board of Trustees of Michigan State UniversityInventor: Bruce E. Dale
-
Publication number: 20110189134Abstract: An object of the present invention is to provide a fermented product containing equol-producing microorganisms in the state of living cells by which equol production ability is maintained. When producing a fermented material by using an equol-producing microorganism, with soybean powder or soybean milk as raw materials, (1) preparing a mother starter by fermentation under anaerobic conditions by using an equol-producing microorganism in the presence of a daidzein species at pH 5.0 or higher, (2) preparing a bulk starter by fermentation under anaerobic conditions by using said mother starter in the presence of a daidzein species at pH 5.0 or higher, and (3) preparing a fermented material by fermentation by using said bulk starter in a medium containing soybean powder or soybean milk, enables production of a fermented material containing microorganisms in the state of living cells in which the equol production ability is maintained.Type: ApplicationFiled: September 18, 2009Publication date: August 4, 2011Applicants: OTSUKA PHARMACEUTICAL CO., LTD., OTSUKA FOODS CO., LTD.Inventors: Yoshikazu Isono, Hisako Mori, Tomomi Ueno, Rieko Endo, Megumi Kumemura, Yasuhiro Abiru, Shigeto Uchiyama
-
Patent number: 7981649Abstract: A device and methods for monitoring status of at least one cell, wherein the cell has a membrane forming a substantially enclosed structure and defining an intracellular space therein. In one embodiment of the present invention, the device includes a first substrate having a first surface and an opposite second surface, a second substrate supported by the first substrate, the second substrate having a first surface, an opposite second surface, a body portion between the first surface and the second surface, a first side surface and an opposite second side surface, wherein the body portion defines a first passage between the first side surface and the second side surface and an opening on the first surface of the second substrate and in fluid communication with the first passage, and sidewalls positioned above the first surface of the second substrate.Type: GrantFiled: August 22, 2008Date of Patent: July 19, 2011Assignee: Vanderbilt UniversityInventors: John P. Wikswo, Franz J. Baudenbacher, Owen McGuiness
-
Publication number: 20110136210Abstract: Disclosed herein are methods of use of methylsulfonylmethane (MSM) to modulate microbial activity, such as to enhance or inhibit the activity of microorganisms. In one example, MSM (such as about 0.5% to 5% MSM) is used to enhance fermentation efficiency, such as to enhance fermentation efficiency associated with the production of beer, cider, wine, a biofuel, dairy product or any combination thereof. Also disclosed are in vitro methods for enhancing the growth of one or more probiotic microorganisms and methods of enhancing growth of a microorganism in a diagnostic test sample. Methods of inhibiting microbial activity are also disclosed. In one particular example, a method of inhibiting microbial activity includes selecting a medium that is susceptible to H1N1 influenza contamination; and contacting the medium with MSM at a concentration of about 10% to about 16% of weight by volume, thereby inhibiting H1N1 influenza microbial activity.Type: ApplicationFiled: February 16, 2011Publication date: June 9, 2011Inventors: Rodney L. Benjamin, Jeffrey Varelman, Anthony L. Keller
-
Publication number: 20110110893Abstract: The present invention provides a therapeutic agent for anaerobic diseases such as solid tumor, comprising in combination a pharmaceutical composition for the treatment of an anaerobic disease containing the transformed anaerobic microorganism as an active component and a pharmaceutical composition containing as an active component an anaerobic microorganism colonization and growth enhancer for enhancing the specific colonization and proliferation of the anaerobic microorganism at an anaerobic disease site. Furthermore, the present invention provides to an anaerobic microorganism colonization and growth enhancer for enhancing colonization and growth of the transformed anaerobic microorganism at a disease site that is in an anaerobic environment.Type: ApplicationFiled: April 17, 2009Publication date: May 12, 2011Applicant: ANAEROPHARMA SCIENCE, INC.Inventors: Takayuki Sasaki, Hitomi Shimizu, Yuko Shimatani-Shibata, Hiromi Yonekura
-
Publication number: 20110105623Abstract: Disclosed herein are methods of use of methylsulfonylmethane (MSM) to modulate microbial activity, such as to enhance or inhibit the activity of microorganisms. In one example, MSM (such as about 0.5% to 5% MSM) is used to enhance fermentation efficiency, such as to enhance fermentation efficiency associated with the production of beer, cider, wine, a biofuel, dairy product or any combination thereof. Also disclosed are in vitro methods for enhancing the growth of one or more probiotic microorganisms and methods of enhancing growth of a microorganism in a diagnostic test sample. Methods of inhibiting microbial activity are also disclosed. In one particular example, a method of inhibiting microbial activity includes selecting a medium that is susceptible to H1N1 influenza contamination; and contacting the medium with MSM at a concentration of about 10% to about 16% of weight by volume, thereby inhibiting H1N1 influenza microbial activity.Type: ApplicationFiled: October 29, 2010Publication date: May 5, 2011Inventors: Rodney L. Benjamin, Jeffrey Varelman, Anthony L. Keller
-
Patent number: 7927639Abstract: The invention concerns a mixture of bacteria. Said mixture is a non starter culture which is free from metabolites and comprises at least one first bacterium selected from the species <i>Propionibacterium jensenii</i> and at least one second bacterium selected from the genus <i>Lactobacillus</i>. Furthermore, food, feeding stuff and medicaments comprising such a mixture, a method for manufacturing and storing such goods and the use of the mixture to inhibit fungi and bacteria are provided.Type: GrantFiled: October 30, 2002Date of Patent: April 19, 2011Assignee: Eidgenossische Technische Hochschule ZurichInventors: Susanne Miescher Schwenninger, Leo Meile
-
Publication number: 20110086797Abstract: Provided are compositions and methods for treating bacterial infections. It is demonstrated herein that bacteria cell wall materials stimulate germination of spores of Gram-positive bacteria, and that such activity requires Ser/Thr kinase PrkC. By modulating one or both, spores (which can be antibiotic resistant) can be stimulated or inhibited from germination, which can be exploited in various methods of therapeutic treatment. Also provided is a method of modulating germination of a spore of a Gram-positive bacterium. Also provided is a method of decontaminating an environment.Type: ApplicationFiled: March 26, 2010Publication date: April 14, 2011Applicant: The Trustees of Columbia University in the City of New YorkInventor: Jonathan Dworkin
-
Publication number: 20110039326Abstract: The present invention is a system for optimizing production of biomass. The system contains one or more growth modules under a shading element that diffuses light. Each of the growth modules has a plurality of vertical growth columns arranged on a bottom manifold. The biomass is grown within a liquid growth medium held within each of the vertical growth columns until it reaches a desired growth. The biomass is then harvested through gravitational flow of the biomass and the liquid growth medium out of the bottom of each growth column. The bottom manifold collects gravitational flow of the biomass and liquid growth media from each growth column and aggregates the output of each individual column into a collective output of the growth module.Type: ApplicationFiled: August 12, 2010Publication date: February 17, 2011Applicant: AlgEternal Technologies, LLCInventors: Milton Hugh Morris, Katon Hughes Deal Morris, John Michael Harris, Michael Donavan Jochum, JR.
-
Publication number: 20110033912Abstract: A photobioreactor apparatus in which a reaction chamber contains a slurry of water, nutrients and photosynthetic organisms. The sidewall of the reaction chamber is constructed of translucent material, thereby permitting light to be conveyed into the slurry to promote photosynthesis. The interior of the reaction chamber is in fluid communication with a gas dispenser. A lift member is disposed in the reaction chamber and gas is introduced in the slurry beneath the lift member, thereby providing buoyancy to lift the lift member, thereby providing agitation and movement of the slurry within the photobioreactor and enhancing growth of photosynthetic organisms.Type: ApplicationFiled: August 3, 2010Publication date: February 10, 2011Inventor: David D. Slagel
-
Patent number: 7846708Abstract: The present invention describes a method for increasing the survival of the bacteria of Rhizobium genus, comprising the steps of: making the bacteria to grow in a chemically defined medium; keeping the bacteria in growth stationary phase for a proper period of time; exposing the bacteria to effective quantities of indole-3-acetic acid (IAA). Within the invention scope there is an alternative method to increase the survival of the bacteria of the Rhizobium genus by means of genetic engineering comprising the steps of: making a recombinant vector codifying enzymes able to produce IAA to express in effective way in said bacteria; making the bacteria to grow in chemically defined culture medium; keeping the bacteria in growth stationary phase for a proper period of time.Type: GrantFiled: June 13, 2006Date of Patent: December 7, 2010Assignee: Consiglo Nazionale delle RicherchInventor: Roberto Defez
-
Publication number: 20100279367Abstract: Fermentation media containing an isoflavone-depleted soybean meal or isoflavone-depleted soybean meal product and at least one exogenous added ingredient that comprises a substrate for microbial growth are provided. Methods of making a fermentation medium comprising an isoflavone-depleted soybean meal or isoflavone-depleted soybean meal product and methods for obtaining a fermentation product are also provided. The present invention is further directed to fermentation broths obtained by the media and methods. The present invention is also directed to feed additives produced from fermentation broths obtained by the methods.Type: ApplicationFiled: April 27, 2010Publication date: November 4, 2010Applicant: FERMALOGIC, INC.Inventor: J. Mark Weber
-
Publication number: 20100247500Abstract: The survival of lactic acid bacterial strains such as probiotic bacteria contained in yogurt etc. is improved. A lactic acid bacterium survival improver including a propionic acid bacterium fermentation product to improve the survival of a lactic acid bacterium. The propionic acid bacterium is a bacterium belonging to the genus Propionibacterium. The bacterium belonging to the genus Propionibacterium is Propionibacterium freudenreichii.Type: ApplicationFiled: November 18, 2008Publication date: September 30, 2010Inventors: Kakuhei Isawa, Hideaki Uchida, Keisuke Furuichi, Fuyuko Yamamoto
-
Publication number: 20100240114Abstract: The present invention provides methods and systems for the production of macroalgae in a manner to provide a sustained, economical source of biomass that may be used in various end-use processes, including energy production. The invention provides specific combinations of macroalgae types, saltwater growth medium compositions, and open pond water containers that results in biomass production beyond what may occur naturally without the required manipulation. Specifically, macroalgae that produce an exoskeleton in the presence of brackish water (e.g., stoneworts) have been found to provide excellent biomass production under the conditions of the invention.Type: ApplicationFiled: March 17, 2010Publication date: September 23, 2010Inventors: Miles Palmer, Bart R. Reid
-
Patent number: 7794763Abstract: The present invention provides a bacterium belonging to the genus Bifidobacterium, which can exhibit a high viability in the storage under agitation and can produce a fermented food containing a large number of viable bacterial count. The present invention further provides a fermented food, which contains the bacterium belonging to the genus Bifidobacterium and exhibits various physiological effects such as inhibitory action against harmful intestinal bacteria and intestinal function controlling effects. The present invention further provides a bacterium belonging to the genus Bifidobacterium having a rate of viability of 30% or more, when the bacterium is stored in the aerobic condition under agitation at 10° C. for 14 days after culturing in a medium containing milk as a main ingredient until obtaining a viable count of 1×108 cfu/ml or more, and fermented food using the same.Type: GrantFiled: November 1, 2002Date of Patent: September 14, 2010Assignee: Kabushiki Kaisha Yakult HonshaInventors: Masaki Serata, Hirokazu Tsuji, Koichiro Sonoike
-
Patent number: 7790435Abstract: Quiescence is induced in cells using indole compounds. Expression continues from extra-chromosomal vectors within the cells during quiescence, while chromosomal expression is suppressed. The cells may be used as factories for the production of large amounts of polypeptides of interest, particularly polypeptides which normally have an adverse effect on cell viability or growth. Expression from an extra-chromosomal vector of interest may be monitored, in view of the reduced background expression from the chromosome. Vector copy number may be amplified. Cell cycles may be synchronized.Type: GrantFiled: December 18, 2006Date of Patent: September 7, 2010Assignee: Cambridge Microbial Technologies LimitedInventors: David Keith Summers, Ellie Chant
-
Patent number: 7790208Abstract: A process of producing a rich-flavor soy sauce, including mixing soy sauce koji and salt water in a tank for preparing moromi mash, adding soy sauce and soy sauce koji at an appropriate point in time during the period of fermentation and aging, and subsequently effecting further aging. The process does not require any special treatment, and is quite convenient, in that it employs conventional process steps for producing a soy sauce. The resultant soy sauce has a light color and yet gives a rich flavor comparable to that of regular soy sauce, has a rich taste comparable to that of saishikomi-shoyu having a total nitrogen content of not less than 2% (W/V), and is mild in terms of saltiness.Type: GrantFiled: February 4, 2005Date of Patent: September 7, 2010Assignee: Yamasa CorporationInventors: Yoshikazu Orimo, Tatsuo Yamazaki
-
Patent number: 7770322Abstract: A process for cultivating photosynthetic microbes comprising Closed Systems for continuous cultivation and Open Systems for batch cultivation, in which (a) the Closed System Area occupies no more than 20% of the Total Land Area of the cultivation facility; (b) batch cultures in the Open Systems are initiated with an inoculum from the Closed Systems containing a cell biomass of no less than 5% of the carrying capacity of said Open System; (c) the doubling rate of said photosynthetic microbe is no less than once every 16 hours; and (d) the residence time of the batch culture in said Open System is no more than a period of 5 days.Type: GrantFiled: June 7, 2006Date of Patent: August 10, 2010Assignee: HR Biopetroleum, Inc.Inventors: Mark Edward Huntley, Donald G Redalje
-
Publication number: 20100184194Abstract: The present invention relates to a method for cultivating carotenoid rich golden yellow algae by varying the ratio of carbon to nitrogen content in the culture medium during cultivation and supplementing the media periodically with citrate and acetate compounds to enhance the carotenoid production and produce change in the colour of blue-green algae to golden yellow.Type: ApplicationFiled: June 17, 2008Publication date: July 22, 2010Inventor: Baburao Kumble Nagnath
-
Patent number: 7759109Abstract: A bacterial growth medium for promoting auto-induction of transcription of cloned DNA in cultures of bacterial cells grown batchwise is disclosed. The transcription is under the control of a lac repressor. Also disclosed is a bacterial growth medium for improving the production of a selenomethionine-containing protein or polypeptide in a bacterial cell, the protein or polypeptide being produced by recombinant DNA techniques from a lac or T7lac promoter, the bacterial cell encoding a vitamin B12-dependent homocysteine methylase. Finally, disclosed is a bacterial growth medium for suppressing auto-induction of expression in cultures of bacterial cells grown batchwise, said transcription being under the control of lac repressor.Type: GrantFiled: April 4, 2008Date of Patent: July 20, 2010Assignee: Brookhaven Science Associates, LLCInventor: F. William Studier
-
Patent number: 7745157Abstract: The present invention relates to an adjuvant derived from human lymphocytes. The adjuvant can be used in combination with traditional vaccines or cancer immunotherapy, to enhance the response of the patient's immune system to the vaccine or other immunotherapeutic agent. The adjuvant is derived from the supernatant collected from cultured activated lymphocytes.Type: GrantFiled: February 20, 2004Date of Patent: June 29, 2010Assignees: University of Maryland, Baltimore, Hasumi LLCInventors: Kenichiro Hasumi, Dean LeMar Mann, Kim Graulich Hankey, Kristina Michelle Holt
-
Publication number: 20100120123Abstract: A microbial leaching process is carried out on a heap of particulate chalcopyrite ore by adding carbon dioxide to an air stream directed into the heap at least when the heap is at mesophilic temperatures, to stimulate growth, and to achieve a sufficiently high concentration, of mesophilic microbial strains in the heap so as to generate heat, at moderate thermophilic temperatures, at a rate which exceeds the rate of heat loss from the heap.Type: ApplicationFiled: October 5, 2007Publication date: May 13, 2010Inventors: Chris Andre DuPlessis, Sanet Helena Minnaar
-
Patent number: 7713733Abstract: An apparatus and methods for detecting at least one analyte of interest either produced or consumed by a plurality of cell. In one embodiment of the present invention, the method includes the steps of providing a housing defining a chamber, placing a plurality of cells in the chamber, and simultaneously detecting at least two analytes of interest either produced or consumed by the plurality of cells in the chamber.Type: GrantFiled: August 6, 2002Date of Patent: May 11, 2010Assignee: Vanderbilt UniversityInventors: David Cliffel, Franz J. Baudenbacher, John P. Wikswo, Sven Eklund, R. Robert Balcarcel, Jonathan M. Gilligan
-
Publication number: 20100112005Abstract: The present invention relates to pharmaceutical compositions of activated botulinum toxin type B. In particular, the present invention relates to botulinum toxin type B pharmaceutical compositions wherein at least 90% of said botulinum toxin type B is activated—i.e., “nicked”. The invention also relates to a process of activating botulinum toxin type B wherein at least 90% of said botulinum toxin type B is nicked. The invention further relates to methods for the treatment of a variety of overactive or neuromuscular diseases, pain, inflammatory and cutaneous disorders comprising administering a pharmaceutical composition of activated botulinum toxin type B wherein at least 90% of said botulinum toxin type B is nicked.Type: ApplicationFiled: November 3, 2009Publication date: May 6, 2010Applicant: Solstice Neurosciences, Inc.Inventors: Sheryl Ann Garcia, Bret Marin, Shaji Joseph
-
Patent number: 7704722Abstract: Methods for promoting and suppressing auto-induction of transcription of cloned DNA in cultures of T7 expression strains are disclosed.Type: GrantFiled: April 27, 2007Date of Patent: April 27, 2010Assignee: Brookhaven Science Associates, LLCInventor: F. William Studier
-
Publication number: 20100092804Abstract: The present invention relates to a method for preparing a microbial fuel cell, wherein the method includes: (i) inoculating an anodic liquid medium in contact with an anode of the microbial fuel cell with one or more types of microorganisms capable of functioning by an exoelectrogenic mechanism; (ii) establishing a biofilm of the microorganisms on and/or within the anode along with a substantial absence of planktonic forms of the microorganisms by substantial removal of the planktonic microorganisms during forced flow and recirculation conditions of the anodic liquid medium; and (iii) subjecting the microorganisms of the biofilm to a growth stage by incorporating one or more carbon-containing nutritive compounds in the anodic liquid medium during biofilm formation or after biofilm formation on the anode has been established.Type: ApplicationFiled: October 15, 2008Publication date: April 15, 2010Applicant: UT-BATTELLE, LLCInventor: Abhijeet P. Borole
-
Patent number: 7687246Abstract: The present invention relates to a biological process for producing carotenoids utilizing a microorganism which is capable of producing carotenoids and belonging to the genus Xanthophyllomyces (Phaffia) in the presence of an inhibitor for biosynthesis of sterols from farnesyl pyrophosphate.Type: GrantFiled: April 10, 2003Date of Patent: March 30, 2010Assignee: DSM IP Assets B. V.Inventors: Tatsuo Hoshino, Setsuko Masuda, Yutaka Setoguchi
-
Patent number: 7674609Abstract: Crypthecodinium cohnii, or microorganisms derived from Crypthecodinium cohnii, are grown in a culture medium including propionic acid. The propionic acid increases the production of one or more of dry cell weight, total lipid and docosahexaenoic acid.Type: GrantFiled: February 4, 2002Date of Patent: March 9, 2010Assignee: The University of HullInventors: Colin Ratledge, Alistair James Anderson, Kanagasooriyam Kanagachandran
-
Patent number: 7666635Abstract: A novel biotechnological process for the preparation of nitriles, starting from amides, is described. Micro-organisms of the genus Amycolatopsis, Actinomadura or Rhodococcus are employed for this process.Type: GrantFiled: October 31, 2007Date of Patent: February 23, 2010Assignee: Lonza, AGInventors: Karen Tracey Robins, Toru Nagasawa
-
Publication number: 20100004324Abstract: In one aspect, the invention relates to compounds and methods useful for activating heme sensor systems; for decreasing virulence of bacteria, for example, Staphylococcus aureus; pharmaceutical compositions comprising the compounds; and methods of treating microbial-related disorders. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.Type: ApplicationFiled: June 25, 2009Publication date: January 7, 2010Inventors: Eric Skaar, Devin Stauff, Olusegun O. Aranmolate
-
Patent number: 7642069Abstract: An improved process for the production of streptokinase using a genetically engineered strain of Escherichia coli which overproduces streptokinase intracellularly and more particularly, the overall process disclosed herein, concerns with an improvement in the fermentative production of streptokinase using an optimized growth medium mainly comprised of simple salts and trace-elements; thus, in principal, the present process constitutes an improved and more economical means for the production of streptokinase which may be useful in thrombolytic therapy.Type: GrantFiled: December 9, 2005Date of Patent: January 5, 2010Assignee: Council of Scientific & Industrial ResearchInventors: Vinay Venkatrao Vyas, Govindan Rajamohan, Ramandeep, Kanak Lata Dikshit